Understanding the innate immune system is essential for the development of new therapies for the treatment of microbial infection, the management of autoimmune disorders and the provision of protective immunity via vaccination. My group investigates two members of the intracellular NOD-like receptor family, NOD1 and NOD2. These proteins are activated by fragments of bacterial peptidoglycan; γ-D-glutamyl-meso-diaminopimelic acid for NOD1 and muramyl dipeptide for NOD2.
Leucine rich repeat (LRR) homology models. The LRR region of NOD1 (purple) and NOD2 (blue) were modelled using the human ribonuclease inhibitor complexed with ribonuclease I (pdb 1z7x) as a template
Ligand recognition stimulates receptor oligomerisation and initiates a signalling cascade that ultimately leads to the upregulation of a pro-inflammatory immune response. NOD1 and NOD2 are both associated with a predisposition to inflammatory disorders. The best characterised of these is the role of NOD2 single nucleotide polymorphisms in the inflammatory bowel disorder Crohn’s Disease.
Our work is specifically interested in developing an understanding of how these proteins recognise their bacterial ligands and how they interact with their signalling adaptor molecule RIP2. We are particularly interested in the impact of changes in protein structure on these processes. To achieve these aims we are using a variety of biochemical and biophysical techniques in addition to x-ray crystallography.
Lab members
Joseph Boyle, Sophie Gooch, Chris Howard
References
Monie TP, Bryant CE, Gay NJ. Activating Immunity – Lessons from the TLRs and NLRs. Trends Biochem Sci. (2009) Nov;34(11):553-61
Monie TP, Gay NJ, Gangloff M. Bioinformatic analysis of toll-like receptor sequences and structures. (2009) Methods Mol Biol.;517:1-11.
Monie TP, Moncrieffe MC, Gay NJ. (2009) Structure and regulation of cytoplasmic adaptor proteins involved in innate immune signalling. Immunol Rev. 2009 Jan; 227(1):161-75.
Walsh C, Gangloff M, Monie T, Smyth T, Wei B, McKinley TJ, Maskell D, Gay N, Bryant C. (2008) Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J Immunol. Jul 15;181(2):1245-54.